Methyl 3-hydroxy-4-nitrobenzoate(CAS: 713-52-0)

Methyl 3-hydroxy-4-nitrobenzoate (CAS: 713-52-0) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes hazards related to skin and eye irritation, and possible respiratory sensitization. In the European Union, it falls under the European Chemicals Agency's (ECHA) REACH regulations. In the United States, it is regulated by the Food and Drug Administration (FDA) for pharmaceutical use and by the Environmental Protection Agency (EPA) for environmental protection concerns.

Alternative reagents such as Methyl 4-nitrobenzoate or Methyl 3-nitrobenzoate can be used as substitutes in certain synthetic processes for Methyl 3-hydroxy-4-nitrobenzoate (CAS: 713-52-0). These alternatives may offer different reactivity but can be explored based on the specific requirements of the synthesis.

The market for Methyl 3-hydroxy-4-nitrobenzoate (CAS: 713-52-0) is driven by its use in pharmaceuticals, particularly as an intermediate in drug synthesis. Research trends focus on its applications in medicinal chemistry, where it is used to develop new drugs with specific properties. Additionally, there is ongoing exploration of its use in other industries such as agriculture and materials science, driven by its unique chemical properties.

Waste containing Methyl 3-hydroxy-4-nitrobenzoate (CAS: 713-52-0) should be handled according to local environmental protection laws. Typically, it should be collected in a sealed container and disposed of through a professional waste disposal service. Incineration or other safe disposal methods should be employed to ensure the waste is treated in a manner that minimizes environmental impact and complies with regulatory requirements.